Glaukos Announces Planned Retirement of Chief Financial Officer Richard L. Harrison

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that its Chief Financial Officer, Richard L. Harrison, has notified the company of his plans to retire in 2017 in order to dedicate more time to family and personal interests. Mr. Harrison will remain in his current role until a su